Patent · US Active

Anti-serum albumin binding variants

US9534043B2 · kind B2 · utility

0Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 17, 2010
Grant dateJan 3, 2017
Priority date
Expiry dateDec 5, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/31
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to improved variants of the anti-serum albumin immunoglobulin single variable domain DOM7h-11, as well as ligands and drug conjugates comprising such variants, compositions, nucleic acids, vectors and hosts.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.